22nd Century Group, Inc. Share Price

Equities

XXII

US90137F3010

Tobacco

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
1.73 USD -5.46% Intraday chart for 22nd Century Group, Inc. +6.79% -41.93%
Sales 2024 * 33.53M 2.68B Sales 2025 * 34.53M 2.76B Capitalization 10.46M 837M
Net income 2024 * -41M -3.28B Net income 2025 * -32M -2.56B EV / Sales 2024 * 0.31 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.3 x
P/E ratio 2024 *
-0.09 x
P/E ratio 2025 *
-0.11 x
Employees 64
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.65%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.46%
1 week+6.79%
Current month-9.90%
1 month-17.71%
3 months-37.14%
6 months-78.20%
Current year-41.93%
More quotes
1 week
1.53
Extreme 1.53
1.97
1 month
1.45
Extreme 1.45
4.31
Current year
1.45
Extreme 1.45
4.31
1 year
1.45
Extreme 1.45
180.91
3 years
1.45
Extreme 1.45
1 377.60
5 years
1.45
Extreme 1.45
1 456.80
10 years
1.45
Extreme 1.45
1 456.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 11-27
Director of Finance/CFO 57 14/06/22
Chief Tech/Sci/R&D Officer - 30/12/17
Members of the board TitleAgeSince
Director/Board Member 77 11/09/22
Chief Executive Officer 66 11-27
Director/Board Member 64 18/07/23
More insiders
Date Price Change Volume
26/04/24 1.73 -5.46% 780,171
25/04/24 1.83 -0.54% 279,679
24/04/24 1.84 +10.18% 1,015,942
23/04/24 1.67 +1.21% 193,958
22/04/24 1.65 +1.85% 238,511

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
Sector
Tobacco
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.73
Average target price
-
Consensus